Cargando…
IL‐7 germline variant: setting the stage for immune‐related adverse events
Treatment with immune checkpoint inhibitors (ICIs) is frequently associated with immune‐related adverse events (irAEs). A new study identified an interleukin 7 (IL‐7) allelic variant—rs16906115—as a major risk factor for the development of ICI‐associated irAEs. This association is of great significa...
Autores principales: | Issaoui, Hussein, Ricci, Jean‐Ehrland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980302/ https://www.ncbi.nlm.nih.gov/pubmed/36748568 http://dx.doi.org/10.1002/1878-0261.13392 |
Ejemplares similares
-
Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy
por: Zubiri, Leyre, et al.
Publicado: (2019) -
Microbiome transplantation and modulation of immune related adverse events
por: Smibert, Olivia C., et al.
Publicado: (2019) -
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
por: Haratani, Koji, et al.
Publicado: (2020) -
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
por: Kerepesi, Csaba, et al.
Publicado: (2020) -
Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse Events
por: Oswalt, Cameron J., et al.
Publicado: (2022)